Pharma Mar (OTCMKTS:PHMMF – Get Free Report) crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $93.44 and traded as low as $77.7412. Pharma Mar shares last traded at $77.7412, with a volume of 100 shares trading hands.
Pharma Mar Stock Performance
The business’s 50 day simple moving average is $93.11 and its two-hundred day simple moving average is $93.31.
About Pharma Mar
Pharma Mar, SA is a Spanish biopharmaceutical company focused on discovering, developing and commercializing innovative medicines derived from marine organisms. The company specializes primarily in oncology and maintains a research platform dedicated to identifying novel compounds with potential anticancer activity.
Its principal products include Yondelis (trabectedin), an anticancer treatment used in certain cases of advanced soft-tissue sarcoma and ovarian cancer, and Zepzelca (lurbinectedin), a therapy developed for patients with metastatic small-cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
